Community Pharmacies Debate
Full Debate: Read Full DebateAndrew Gwynne
Main Page: Andrew Gwynne (Labour (Co-op) - Gorton and Denton)Department Debates - View all Andrew Gwynne's debates with the Department of Health and Social Care
(2 years, 2 months ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
It is a pleasure to serve under your chairmanship, Sir Gary. I add my congratulations to my hon. Friend the Member for Bootle (Peter Dowd) on securing the debate, and I congratulate him and Members across the House on putting forward a compelling argument for supporting our community pharmacy sector and increasing its role in the provision of localised community healthcare.
We have heard from Members from across the House that community pharmacies are the cornerstone of our local areas. For many people, community pharmacists are the most accessible healthcare professionals in the NHS, and their work is invaluable. We have heard that more than 89% of the population is estimated to have access to a community pharmacy within a 20-minute walk, but, as my hon. Friend rightly pointed out, access is significantly higher, at 99%, in areas of the highest deprivation.
We have always known that community pharmacies are important, but it was felt acutely during the pandemic. Community pharmacies helped to administer 24 million covid vaccines and were at the forefront of our response to the virus. In 2020-21, they delivered more than 4 million flu vaccinations—an increase of 75% on the year before. Indeed, as the hon. Member for Southend West (Anna Firth) pointed, community pharmacies carried us through the pandemic and reacted with extraordinary speed to a virus that shut down the rest of the country. It is therefore essential that we not only protect this vital community resource but equip it for the future.
As has been noted throughout the debate, there are two broad areas of concern within the sector, and I would appreciate the Minister’s assessment of them. The first relates to resources. Despite the additional demand for services, there has been no increase in funding for the pharmacy network since 2014, and there have been cuts of around £200 million since 2016. The current framework, agreed in 2019, has not been adjusted, despite the covid-19 pandemic, and we have seen central Government’s failure to adapt. This has resulted in pharmacies being unable to meaningfully invest in staff and has been detrimental to infrastructure development as well as innovation.
What is perhaps most worrying, however, is that an EY study in 2020 found that 40% of the large pharmacy chains sampled were operating at a loss. That is not sustainable, and unless action is taken, we could see pharmacies shut and that vital point of access for people close. I think there is consensus across all parties, including from the Minister, that we want to avoid that, so I would be grateful if she could outline what steps the Government are taking to better support community pharmacies and what assessment her Department has made of the potential impact of fiscal pressures on the sector. Furthermore, has the Department of Health and Social Care made any assessment of the additional pressures that the pandemic has placed on pharmacies? Will that inform the next community pharmacy contractual framework?
The second issue I would like to focus on is strategy and workforce. That will not come as a surprise to the Minister, given the Opposition day debate in the main Chamber earlier. There has been a distinct lack of overarching Government strategy when it comes to workforce planning over the past decade, including in relation to community pharmacies. The community pharmacy model that the NHS needs has drastically changed, as have the needs of patients. As far as I am aware, there has not been any strategy outlining the Government’s ambitions for the sector. Instead, we have seen short-term thinking, a real-terms funding decline and radio silence on the future of this vital resource. That needs to change, and I impress on the Minister the urgency of working with her DHSC colleagues to develop a strategy for community pharmacies that is fit for the future. Crucially, it needs to address the workforce issues that have been reported by parts of the sector, particularly in rural areas, where the increase in patient demand is putting pharmacies under more pressure.
I understand that the Government will argue that extra resource is going into the NHS, but we must not get into the trap of taking community pharmacies for granted, and we need to build a resilient, innovative and adaptive service for the future. We must utilise community pharmacies to tackle the key issues of our time. For example, many pharmacies already offer a range of services geared towards tackling health inequalities, but the local commissioning structures mean that access is not equal throughout the country. There is a real opportunity for central Government to step in and to ensure that no matter where people live, they can access weight-management services, emergency contraception, smoking-cessation services and much more.
Community pharmacies are already embedded in communities. They are trusted by local people. We need, therefore, to ensure that the Government give full support to the sector. Every Member who has spoken would wholeheartedly support the Minister to make sure that happens.
I kindly ask the Minister to leave 30 seconds for Mr Dowd to speak at the end.